| Application no. and date | 01935373.9 (espacenet) (Federated) (European Patent Register), 20010510 | | Patent/reg. no. and date | DK/EP 1307197, 20060405 | | Publication date | 20030507 | | Priority no. and date | US 204143 P, 20000515 | | EP pub. no. and date |
EP 1307197 20030507 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 86 Morris Avenue
Summit, New Jersey 07901, US | | Applicant ref. no. | 125996 | | Inventor | BARER, Sol, 625 Westfield Avenue
Westfield, NJ 07090, US,
ZEITLIN, Andrew, 29 Riverside Drive, Basking Ridge
New Jersey 07920, US,
ZELDIS, Jerome, B., 157 Christopher Drive
Princeton, NJ 08540, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/47 (2006.01) , A61P 35/00 (2006.01) , A61K 31/445 (2006.01) , A61K 31/47 (2006.01) | | Title | Sammensætninger til behandling af cancer indeholdende en topoisomeraseinhibitor og thalidomid | | Int. application no. | US2001015327 | | Int. publication no. | WO2001087307 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
